Exscientia steps up AI-powered drug discovery with $60M Allcyte acquisition
apark
Tue, 06/15/2021 – 09:28
Exscientia steps up AI-powered drug discovery with $60M Allcyte acquisition
Read more on FierceBiotech
You may also like
news & analysis
Deploying machine learning to improve mental health
February 25, 2022, by Alison Gold | Danny Gross | Abdul Latif Jameel Clinic for Machine Learning in Health
A machine-learning expert and a psychology researcher/clinician may seem an unlikely duo. But MIT’s Rosalind Picard and ...
Read more on MIT News - Artificial intelligence
news & analysis
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
October 14, 2021, by PR Newswire:
LONDON, Oct. 14, 2021 /PRNewswire/ — In a significant milestone for its (AI)-driven drug discovery platform, BenevolentAI ...
Read more on PR Newswire:
news & analysis
Pathway Raises $1.3 Million to Scale its AI-Powered Medical Knowledge Platform
October 14, 2021, by Business Wire Technology News
MONTREAL–(BUSINESS WIRE)–A solution to combat medical information overload, a major contributor to clinician burnout.
Read more on Business Wire Technology News
More in SDG 3. GOOD HEALTH & WELL-BEING
news & analysis
Robots and machine learning researchers combine forces to speed up the drug development process
October 14, 2021, by Articles on TechRepublic
IBM Research and Arctoris announce a research collaboration to test a closed-loop platform.
Read more on Articles on TechRepublic
news & analysis
The Secret to Developing Effective AI for Humanitarian Action? (Spoiler alert: it’s not a hackathon)
September 8, 2021, by Sarah Spencer
The Challenge As the world continues to battle COVID-19, a lesser-known public health crisis endures: antimicrobial resistance ...
Read more on The Good AI
news & analysis
Interview with Mo Abdolell, Founder and CEO of Densitas
January 1, 1970, by Caroline Lair
Sustainable breast cancer screening service delivery requires efficient patient and process management. Today we meet Mo Abdolell, ...
Read more on The Good AI